Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: Diagnosis and Support in the UK

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a rare congenital condition affecting the female reproductive system. It occurs in approximately 1 in every 4,500 to 5,000 female births. In women with MRKH, the uterus (womb) and the upper part of the vaginal canal either do not develop at all or are significantly underdeveloped.

Importantly, the external genitalia appear typical, and the ovaries are usually fully functional, producing normal levels of female hormones. This means that secondary sexual characteristics, such as breast development and pubic hair, occur as expected during puberty. However, because the uterus is absent or non-functional, menstruation does not occur. This is often the first sign that leads to a clinical investigation in the UK.

The most common symptom of MRKH syndrome is primary amenorrhoea, which is the medical term for when a girl reaches the age of 16 without having her first period. Because other signs of puberty are normal, the condition often remains undetected until the mid-teens.

Other symptoms or signs may include:

• Difficulties or discomfort when attempting sexual intercourse due to a shortened vaginal canal.
• Recurrent pelvic pain (in rare types where a small amount of uterine tissue is present but cannot shed).
• Associated issues with the kidneys or skeletal system (seen in Type 2 MRKH).
• Hearing loss or heart defects in very rare cases.

If you or your daughter have reached 16 without a period, it is essential to speak to a doctor. While MRKH is a rare cause, it is one of the conditions UK clinicians will screen for alongside hormonal imbalances or PCOS.

In the United Kingdom, the diagnostic pathway typically begins with a consultation with a General Practitioner (GP). Following an initial history and physical examination, the GP will usually arrange for blood tests to check hormone levels (such as FSH, LH, and oestrogen). In MRKH, these hormone levels usually fall within the normal range, indicating the ovaries are working.

Imaging and Referrals

If the hormone levels are normal but periods are absent, the next step is usually a pelvic ultrasound scan. This is used to visualise the internal reproductive organs. If the ultrasound is inconclusive, a Magnetic Resonance Imaging (MRI) scan is the gold standard for confirming the absence or underdevelopment of the uterus and vagina. According to NICE and NHS guidelines, patients suspected of having MRKH should be referred to a specialist centre, such as the National Hospital for Women's Health or specific adolescent gynaecology clinics, for expert multidisciplinary support.

Management of MRKH syndrome is highly individualised and focused on the patient's physical and emotional needs. It is not always necessary to have surgery or intervention unless the patient chooses to for the purpose of sexual function.

• Vaginal Dilators: The first-line approach in the UK for creating or lengthening the vaginal canal is usually self-dilation. This involves using medical-grade dilators over several months to gradually stretch the vaginal tissue.
• Surgical Options: If dilation is not effective or desired, various surgical procedures (vaginoplasty) can be performed to create a functional vaginal canal.
• Psychological Support: Receiving a diagnosis of MRKH can be life-changing. Accessing counselling and peer support groups is a vital part of the care plan offered by the NHS.

One of the most distressing aspects of an MRKH diagnosis is the impact on future fertility. Because the uterus is absent, a woman with MRKH cannot carry a pregnancy herself. However, because the ovaries are usually healthy and produce eggs solution is possible.

In the UK, women with MRKH have several options for starting a family, including:

• IVF and Surrogacy: Eggs can be harvested from the ovaries, fertilised with a partner's or donor’s sperm, and the resulting embryo can be carried by a gestational surrogate.
• Adoption: Many women choose to build their families through the UK’s adoption pathways.
• Uterine Transplant: This is a developing field. The first successful womb transplants have taken place in the UK, though this is currently only available through highly specialised clinical trials and is not yet a routine NHS treatment.

While a final diagnosis of MRKH requires physical imaging, speaking to an online doctor in the UK is a practical first step for those experiencing anxiety about delayed puberty or primary amenorrhoea. You can speak to a GP online to discuss your symptoms in a calm, private environment. The GP can provide an initial assessment, explain the potential causes for a lack of periods, and advise on the specific tests you should request from your local NHS surgery.

An online consultation is also a valuable way to access mental health support if you are struggling with a recent diagnosis or the emotional impact of reproductive health concerns. Our clinicians can provide guidance on the referral pathways available within the British healthcare system.